Shelton Capital Management Arcturus Therapeutics Holdings Inc. Transaction History

Shelton Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $100,485 - $170,401	-7,700 Reduced 14.53%	45,300 $671,000
Q1 2022 May 12, 2022	BUY	$17.64 - $39.57 $88,200 - $197,850	5,000 Added 10.42%	53,000 $1.43 Million
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $278,800 - $582,500	10,000 Added 26.32%	48,000 $2.29 Million
Q2 2021 Aug 12, 2021	BUY	$25.79 - $42.11 $201,162 - $328,458	7,800 Added 25.83%	38,000 $1.29 Million
Q1 2021 May 14, 2021	BUY	$38.75 - $86.92 $1.17 Million - $2.62 Million	30,200 New	30,200 $1.25 Million

174

25.5M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $451M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.